Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 2
1967 1
1970 4
1974 2
1975 1
1976 1
1977 1
1978 1
1980 2
1981 3
1982 1
1983 4
1984 2
1989 1
1990 2
1994 1
2006 1
2007 3
2008 7
2009 2
2010 3
2012 1
2013 1
2014 2
2015 2
2016 3
2017 4
2018 5
2019 3
2020 1
2021 2
2022 5
2023 2
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients-efficacy and microbiologic safety.
Moreno AF, Lavín-Alconero L, de Ugarriza PL, Blanco LS, Hernández SC, Burgués JMB, de Miguel MI, Huerta AJG, Zarzuela MP, Boluda B, Humala K, Calabuig ML, Amigo ML, Casas MC, Del Mar García-Saiz M, Verdugo AF, Domínguez JF, Bernal T. Moreno AF, et al. Among authors: calabuig ml. Trials. 2023 Oct 27;24(1):694. doi: 10.1186/s13063-023-07702-5. Trials. 2023. PMID: 37891616 Free PMC article. Clinical Trial.
Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes.
Caballero JC, Dávila J, López-Pavía M, Such E, Bernal T, Ramos F, Calabuig M, Hernández Sánchez JM, Pomares H, Sánchez Barba M, Abáigar M, González B, Merchán B, Sancho-Tello R, Callejas M, Muñoz-Novas C, Cerveró C, Sanz G, Hernández Rivas JM, Díez Campelo M. Caballero JC, et al. Among authors: calabuig m. Ther Adv Hematol. 2024 Jan 4;15:20406207231218157. doi: 10.1177/20406207231218157. eCollection 2024. Ther Adv Hematol. 2024. PMID: 38186638 Free PMC article.
Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19.
Piñana JL, Garcia-Sanz R, Martino R, Garcia-Roa M, Martin-Martin GA, Risco-Gálvez I, Tormo M, Martinez-Barranco P, Marcos-Corrales S, Calabuig M, Conesa V, Teruel A, Ruiz-Pérez S, Solano C, Navarro D, Cedillo Á, Sureda A. Piñana JL, et al. Among authors: calabuig m. Blood Adv. 2022 Jan 8;6(3):848-853. doi: 10.1182/bloodadvances.2021006326. Blood Adv. 2022. PMID: 34905620 Free PMC article. No abstract available.
One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients.
Piñana JL, Vazquez L, Calabuig M, López-Corral L, Martin-Martin G, Villalon L, Sanz-Linares G, Conesa-Garcia V, Sanchez-Salinas A, Gago B, Facal A, Risco-Gálvez I, Olave MT, Espigado I, Lopez-Jimenez J, Hernández-Rivas JÁ, Avendaño-Pita A, Arroyo I, Ferrer E, García-Cadenas I, González-Santillana C, Roldán-Pérez A, Ferrer B, Guerreiro M, Suarez-Lledó M, Camara A, Campos-Beltrán D, Navarro D, Cedillo Á, Sureda A, Solano C; Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC); Martino R. Piñana JL, et al. Among authors: calabuig m. Blood Cancer J. 2023 Jan 5;13(1):8. doi: 10.1038/s41408-022-00778-3. Blood Cancer J. 2023. PMID: 36599843 Free PMC article.
Incidence and clinical correlates of NFE2 mutations in myeloid neoplasms.
Martín Castillo I, Villamón E, Calabuig M, Pastor I, Ferrer-Lores B, Amat P, Mas E, Castillo I, Blanco S, Solano C, Hernández-Boluda JC, Tormo M. Martín Castillo I, et al. Among authors: calabuig m. Br J Haematol. 2024 Aug;205(2):733-737. doi: 10.1111/bjh.19579. Epub 2024 Jun 6. Br J Haematol. 2024. PMID: 38840560 No abstract available.
Multi-body-site colonization screening cultures for predicting multi-drug resistant Gram-negative and Gram-positive bacteremia in hematological patients.
Torres I, Huntley D, Tormo M, Calabuig M, Hernández-Boluda JC, Terol MJ, Carretero C, de Michelena P, Pérez A, Piñana JL, Colomina J, Solano C, Navarro D. Torres I, et al. Among authors: calabuig m. BMC Infect Dis. 2022 Feb 21;22(1):172. doi: 10.1186/s12879-022-07154-3. BMC Infect Dis. 2022. PMID: 35189833 Free PMC article.
Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria.
Triguero A, Xicoy B, Zamora L, Jiménez MJ, García O, Calabuig M, Díaz-Beyá M, Arzuaga J, Ramos F, Medina A, Bernal T, Talarn C, Coll R, Collado R, Chen TH, Borrás J, Brunet S, Marchante I, Marco V, López-Cadenas F, Calbacho M, Simiele A, Cortés M, Cedena MT, Pedreño M, Aguilar C, Pedró C, Fernández M, Stoica C, Ribera JM, Sanz G. Triguero A, et al. Among authors: calabuig m. Leuk Res. 2022 May;116:106836. doi: 10.1016/j.leukres.2022.106836. Epub 2022 Mar 26. Leuk Res. 2022. PMID: 35405632
Ceftolozane Pharmacokinetics in a Septic Critically Ill Patient under Different Extracorporeal Replacement Therapies.
Carbonell N, Aguilar G, Ferriols R, Huerta R, Ferreres J, Calabuig M, Juan M, Ezquer C, Colomina J, Blasco ML. Carbonell N, et al. Among authors: calabuig m. Antimicrob Agents Chemother. 2019 Dec 20;64(1):e01782-19. doi: 10.1128/AAC.01782-19. Print 2019 Dec 20. Antimicrob Agents Chemother. 2019. PMID: 31658972 Free PMC article. No abstract available.
76 results